Archive

Category Archives for "Transactions"

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in Close of $11 Million Underwritten Public Offering and NASDAQ Uplisting

lexaria bioscience logo

Press Release – New York, NY – January 14, 2021 – Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: “LEXX”), in a closing of an underwritten public offering of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit. Lexaria uses proprietary drug delivery technology, DehydraTECH™, improving the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. The gross proceeds from the offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses.

The offering was made pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC).

H.C. Wainwright & Co. acted as the sole book-running manager for the Offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Avital Perlman, and associate Jacob Tabman and law clerk Zachary Weiss.

Sichenzia Ross Ference LLP Represents KULR Technology Group, Inc. in $8.0 Million Registered Direct Offering 

kulr logo

Press Release – New York, NY – January 4, 2021 – Sichenzia Ross Ference LLP announced today that it represented KULR Technology Group, Inc. (OTCQB: KULR), in a registered direct offering of 6,400,001 shares of common stock and warrants at a purchase price of $1.25 per share and accompanying warrant. The gross proceeds for the offering were $8.0 million.

continue reading >>

Sichenzia Ross Ference LLP Represents SunHydrogen in $9.0 Million Warrant Exercise Transaction

sun hydrogen logo

Press Release – New York, New York – December 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented SunHydrogen, Inc. (OTC: HYSR), in a transaction in which a warrant holder exercised its registered warrants for the purchase of 120,000,000 shares of common stock at an exercise price of $0.075 per share, and received unregistered warrants to purchase up to 132,000,000 shares of common stock at an exercise price of $0.075 per share. The shares issued upon exercise of the registered warrants were registered on a shelf registration statement on Form S-3. H.C. Wainwright & Co., LLC acted as the exclusive placement agent for the transaction.

continue reading >>

Sichenzia Ross Ference LLP Represents H.C. Wainwright in $2.9 Million Public Offering of Staffing 360 Solutions, Inc.

staffing solutuons logo

Press Release – New York, NY – December 29, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as sole book-running manager in a $2.9 million public offering of the common stock of Staffing 360 Solutions, Inc. (NASDAQ: “STAF”), a company engaged in the execution of an international buy-integrate-build strategy through the acquisition of domestic and international staffing organizations in the United States and United Kingdom. The offering consisted of 4,816,665 shares of common stock, at a public offering price of $0.60 per share, for aggregate gross proceeds of approximately $2.9 million.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $26.4 Million Public Offering of Common Stock of Greenwich LifeSciences, Inc. 

greenwich lifesciences logo

Press Release – New York, NY – December, 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp., as a sole bookrunner in the follow on public offering of 660,000 shares of the common stock of Greenwich LifeSciences, Inc. (NASDAQ: GSLI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery.  The shares were sold to the public at a price of $40.00 per share for gross proceeds of approximately $26,400,000. This offering was made pursuant to a registration statement on Form S-1 (File No. 333-251366) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and subsequently declared effective on December 17, 2020 and a registration statement on Form S-1 (File No. 333-251438) previously filed with the SEC and immediately declared effective on December 17, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $5.5 Million Public Offering of Common Stock of ENDRA Life Sciences Inc.

endra life sciences logo

Press Release – New York, NY – December 18, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, as sole underwriter in the follow on public offering of the common stock of ENDRA Life Sciences (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. The offering consisted of 7,857,286 shares of common stock, and the gross proceeds from the offering were $5,500,100, before deducting underwriting discounts and estimated offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Wunong Net Technology Company Limited in $30 Million Initial Public Offering

wunong net technology logo

Press Release – New York, NY – December 17, 2020 – Sichenzia Ross Ference LLP announced today that it represented Wunong Net Technology Company Limited (Nasdaq: WNW) in a $30 million initial public offering of its ordinary shares. Wunong Net Technology Co. Ltd. (“Wunong”) is a China-based e-commerce company which uses an innovative e-platform to sell a myriad of food products. The offering was comprised of 5,000,000 ordinary shares of Wunong at a price of US$5.00 per share to the public for a total of US$25,000,000 of gross proceeds to Wunong. In addition, the underwriters have purchased 999,910 ordinary shares from a selling shareholder for US$4,999,550 for a total of US$29,999,550 in total gross proceeds from the offering.

continue reading >>

Sichenzia Ross Ference LLP Represents SunHydrogen in $9.0 Million Registered Direct Offering

sun hydrogen logo

Press Release – New York, New York – December 3, 2020 – Sichenzia Ross Ference LLP announced today that it represented SunHydrogen, Inc. (OTC: HYSR), in a registered direct offering of 120,000,000 shares of its common stock and short-term warrants to purchase 120,000,000 shares of common stock.

The combined purchase price for one share of common stock and a warrant to purchase one share of
common stock was $0.075. The gross proceeds from the offering were $9,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents HF Enterprises Inc. in $15.1 Million Initial Public Offering and Nasdaq Listing

hf enterprises inc. logo

Press Release – New York, NY – November 30, 2020 – Sichenzia Ross Ference LLP announced today that it has represented HF Enterprises Inc. (“HFEN” or the “Company”) in connection with the Company’s  initial public offering of common stock and listing on the Nasdaq Capital Market. HFEN is a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities with operation in the United States, Singapore, Hong Kong, Australia and South Korea. The initial public offering consisted of 2,160,000 shares of common stock at a public offering price of $7.00 per share. The gross proceeds were approximately $15.1 million, before deducting offering expenses. The Company’s common stock commenced trading on the Nasdaq Capital Market on November 24, 2020 under the symbol “HFEN”.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./ Alliance Global Partners as Placement Agent in $15M Registered Direct Offering of Arcimoto, Inc.

arcimoto logo

Press Release – New York, NY – November 24, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as lead placement agent in a registered direct offering of 1,132,075 shares of common stock of Arcimoto, Inc. (NASDAQ: FUV), an electric vehicle developer and manufacturer. The offering price was $13.25 per share for gross proceeds of $15 million. The offering was made pursuant to a shelf registration statement previously filed with Securities and Exchange Commission on October 3, 2018, and declared effective on October 17, 2018 by the Securities and Exchange Commission.

continue reading >>

Sichenzia Ross Ference LLP Represents Bullfrog Gold in Acquisition of Assets from Barrick Gold and Concurrent C$22 Million Private Placement

bullfrog gold corp

Press Release – New York, NY – November 5, 2020 – Sichenzia Ross Ference LLP announced today that it represented Bullfrog Gold Corp.  (OTCQB: BFGC) (CSE: BFG) (“Bullfrog Gold”) in the acquisition of all of the equity interest of Bullfrog Mines LLC, the successor by conversion of Barrick Bullfrog Inc. Through the acquisition, Bullfrog Gold acquired rights to 1,500 acres adjoining the company’s Bullfrog Gold deposit. The firm also represented Bullfrog Gold in a concurrent private placement, entered into with Augusta Investments Inc. (“Augusta”) and certain individuals identified by Augusta, of 110,000,000 shares of common stock, and warrants to purchase 110,000,000 shares of common stock. The gross proceeds to Bullfrog Gold from this private placement were C$22,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Jupiter Wellness, Inc. in Initial Public Offering and Nasdaq Listing 

jupiter wellness

Press Release – New York, NY – November 3, 2020 – Sichenzia Ross Ference LLP announced today that it has represented Jupiter Wellness, Inc. (“Jupiter” or the “Company”), in connection with its Initial Public Offering of securities and listing on the Nasdaq Capital Markets. Jupiter is a cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol (CBD) via a multitude of convenient products. The Initial Public Offering consisted of 933,333 units consisting of one share of common stock and one warrant for gross proceeds of $7,000,000, before deducting offering expenses. The shares and warrants began trading on The NASDAQ Capital Market on October 30, 2020, under the symbol “JUPW and JUPWW, respectively.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners in $20 Million Public and Concurrent Registered Direct Offerings of Ring Energy

ring energy inc.

Press Release – New York, NY – October 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners  (“AGP”) as sole book-running manager in an underwritten public offering of 8,343,000 shares of common stock, 13,428,500 pre-funded warrants and 21,771,500 common warrants of Ring Energy, Inc. (NYSE American: REI). The gross proceeds to Ring Energy from this offering were approximately $15,240,000.  The firm also represented AGP as sole placement agent for a concurrent registered direct offering of 3,500,000 shares of common stock, 3,300,000 pre-funded warrants and 6,800,000 common warrants. The gross proceeds to Ring Energy from this offering were approximately $4,760,000.

continue reading >>

Sichenzia Ross Ference LLP Represents H.C. Wainwright in $7.5 Million At-The-Market Offering of Ekso Bionics

ekso bionics

Press Release – New York, NY – October 15, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as sales agent in a $7.5 million At-The-Market Offering (“ATM”) of Ekso Bionics Holdings, Inc. (NASDAQ: “EKSO”) common stock.

The shares were registered on EKSO’s registration statement on Form S-3 (File No. 333-239203), which was declared effective by the SEC on June 26, 2020, and prospectus supplement relating to the ATM filed with the SEC on October 9, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $15 Million Initial Public Offering of Amesite Inc.

amesite logo

Press Release – New York, NY – September 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Laidlaw & Company (UK) Ltd. in the $15 million initial public offering of Amesite Inc., an artificial intelligence software company providing online educational programs for  K-12, college, university and business education, and upskilling. 3,000,000 shares were sold to the public at a price of $5.00 per share. Amesite’s common stock began trading on the Nasdaq Capital Market under the ticker symbol “AMST” on September 25, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $7.25 Million Initial Public Offering of Greenwich LifeSciences, Inc.

greenwich lifesciences logo

Press Release – New York, NY – September 29, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp., as a sole bookrunner in the initial public offering of 1,260,870 shares of the common stock of Greenwich LifeSciences, Inc. (NASDAQ: GSLI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. The shares were sold to the public at at a price of $5.75 per share for gross proceeds of approximately $7,250,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Vuzix in $15.5 Million Registered Direct Offering

vuzix

Press Release – New York, New York – September 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, in a registered direct offering of 3,647,060 shares of its common stock and 6 month common stock purchase warrants. The common stock was sold at a price of $4.25 per share and the warrants have an exercise price of $5.25 per share. The gross proceeds from the offering will be approximately $15,500,000. 

The Sichenzia Ross Ference LLP team was led by Partner Gregory Sichenzia, Counsel Jeffrey Cahlon, and Associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.2 Million Underwritten Public Offering of Avinger Inc. Common Stock

avinger logo

Press Release – New York, NY – August 26, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 11,063,830 shares of common stock of Avinger, Inc. (NASDAQ: “AVGR”), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD). The offering was made pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC).

continue reading >>

Sichenzia Ross Ference LLP Represents Roth Capital Partners, LLC as Sole Bookrunner in $23.5 Million Public Offering of Centrus Energy Corp. Common Stock

Centrus energy corp logo

Press Release – New York, NY – August 25, 2020 – Sichenzia Ross Ference LLP today
announced that it represented Roth Capital Partners, LLC as sole bookrunner, with Lake Street
Capital Markets LLC, as lead manager, in an underwritten public offering of 2,350,000 shares of
the common stock of Centrus Energy Corp. (NYSE American: LEU), a global energy company that
supplies low enriched uranium (“LEU”) for commercial nuclear power plants, at a price of
$10.00 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $6 Million Public Offering of Avinger Inc. Common Stock

avinger logo

Press Release – New York, NY – August 6, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 15,789,474 shares of the common stock of Avinger Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $0.38 per share. The offering was made pursuant to a registration statement on Form S-3 (No. 333-230124) which was previously filed with the Securities and Exchange Commission and declared effective on March 29, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $10 Million Initial Public Offering of 1847 Goedeker Inc. Common Stock

goedekers logo

Press Release – New York, NY – August 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, as sole book-runner in the initial public offering of the common stock of 1847 Goedeker Inc. (NYSE: GOED), a one-stop e-commerce destination for appliances, furniture, home goods, and related products. The offering was comprised of 1,111,200 shares of common stock at a price of $9.00 per share for gross proceeds of $10,000,800, less underwriting discounts and offering expenses. 

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in Close of $3.4 Million Underwritten Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – July 31, 2020 – Sichenzia Ross Ference LLP represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 453,333 shares of the company’s common stock at a price of $7.50 per share, for gross proceeds to DSS of $3.4 million, before deducting underwriting discounts and other offering expenses. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-230740), which was previously filed with the Securities and Exchange Commission and declared effective on May 8, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents Immuron Limited in $20 Million Registered Direct Offering

immuron logo

Press Release – New York, NY – July 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, in a registered direct offering of 1,066,668 American Depositary Shares (“ADSs”), each ADS representing 40 of the Company’s ordinary shares, at a purchase price of $18.75 per ADS for gross proceeds of approximately $20 million.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P/Alliance Global Partners in $5.9 Million Registered Direct Offering of Safe-T Group Ltd.

safe-t logo

Press Release – New York, NY – July 22, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of Safe-T Group Limited (NASDAQ: “SFET”) for gross proceeds of approximately $5.9 million. The offering provided for the issuance of an aggregate of (i) 3,075,000 American depositary shares (“ADSs”) at a purchase price of $1.40 per ADS, and (ii) 1,145,000 pre-funded warrants each to purchase one ADS (“Pre-Funded Warrants”) at a price of $1.40 each, including the Pre-Funded Warrant exercise price of $0.001 per full ADS. The Pre-Funded Warrants will be exercisable at any time after the date of issuance.  continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $5.1 Million Public Offering

genetic technologies logo

Press Release – New York, NY – July 20, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 1,025,000 American Depositary Shares (the “ADSs”), each representing six hundred of the Company’s ordinary shares, at a purchase price of $5.00 per ADS, for gross proceeds of $5.1 million.

continue reading >>

Sichenzia Ross Ference LLP Represents Zynex, Inc. and Selling Shareholder in $55 Million Public Offering of Common Stock

zynexmedical logo

Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP today announced that it represented Zynex, Inc. (NASDAQ: “ZYXI”), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, and a certain shareholder in a public offering of an aggregate of 2,500,000 shares of its common stock at a public offering price of $22.00 per share. The offering was made pursuant to a registration statement on Form S-3 (File No. 333-230128) that was filed with the Securities and Exchange Commission (the “SEC”) and became effective on March 12, 2019, and a registration statement on Form S-3 (File No. 333-232367) that was filed with the SEC and became effective on July 3, 2019, for the shares of common stock being offered by ZYXI and the selling stockholder, respectively.

continue reading >>

Sichenzia Ross Ference LLP Represents INmune Bio, Inc. in $21.74 Million Public Offering of Common Stock

inmunebio logo

Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP announced that it represented INmune Bio Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, in a public offering of 2,173,914 shares of the company’s common stock at a price of $10.00 per share.  The gross proceeds to INMB were $21.74 million, before deducting underwriting discounts and other offering expenses, with net proceeds estimated to be $20 million. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-237368), that was filed with the Securities and Exchange Commission (the “SEC”) and became effective on April 2, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Equillium, Inc. in $150 Million At-The-Market Offering Through Jeffries LLC 

equilliam logo

Press Release – New York, NY – July 16, 2020 – Sichenzia Ross Ference LLP announced that it represented Equillium, Inc. (NASDAQ: “EQ”), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, in an At-The-Market Offering (“ATM”), whereby Equillium may sell up to $150 million of common stock from time-to-time.  Jefferies LLC is acting as the sales agent in connection with the ATM.

continue reading >>

Sichenzia Ross Ference LLP Represents H.C. Wainwright as Sales Agent in $7 Million At-The-Market Offering of BioPath Holdings

bio-path holdings inc logo

Press Release – New York, NY – July 15, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC, as sales agent in an At-The-Market Offering (“ATM”) of BioPath Holdings Inc (NASDAQ: “BPTH”) common stock for gross proceeds of approximately $7 million. The shares were registered on BPTH’s Registration Statement on Form S-3 (File No. 333-231537) filed with the Securities and Exchange Commission on May 16, 2019, and declared effective by the SEC on June 5, 2019, and the prospectus supplement relating to the ATM filed with the SEC on July 14, 2020.

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6.43 Million Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – July 7, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 1,028,800 shares of the company’s common stock at a price of $6.25 per share, for gross proceeds to DSS of $6.43 million, before deducting underwriting discounts and other offering expenses. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-230740), which was previously filed with the Securities and Exchange Commission and declared effective on May 8, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $5.4 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – June 26, 2020 –  Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 20,000,000 shares of Avinger, Inc. (NASDAQ: AVGR) common stock at a price of $0.27 per share, for total gross proceeds of approximately $5.4 million.  Avinger is a leading developer of innovative treatments for peripheral artery disease. 

continue reading >>

Sichenzia Ross Ference LLP Represents Hudson Capital Inc. in $3.7 Million Registered Direct Offering 

china internet nationwide financial services

Press Release – New York, NY – June 24, 2020 – Sichenzia Ross Ference LLP today announced that it represented Hudson Capital Inc.  (NASDAQ: HUSN), in a $3.7 million registered direct offering of its ordinary shares at a price of $0.85 per share. The offering was made pursuant to a registration statement on Form F-3 (File No. 333-233408) which was previously filed with the Securities and Exchange Commission and declared effective on September 19, 2019.

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6 Million Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – June 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 769,230 shares of the company’s common stock at a price of $7.80 per share. The offering was made pursuant to a registration statement on Form S-1 (File No. 333-238587) which was previously filed with the Securities and Exchange Commission and declared effective on June 16, 2020. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.4 Million Public Offering of Digital Ally, Inc. Common Stock

digital ally logo

Press Release – New York, NY – June 5, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,325,581 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company, at a price of $2.15 per share. The underwriters elected to simultaneously close the over-allotment option consisting of 213,953 shares of common stock, bringing the offering’s gross proceeds to approximately $5.4 million, before deducting underwriting discounts and other offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.1 Million Public Offering of Digital Ally, Inc. Common Stock

digital ally logo

Press Release – New York, NY – June 5, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 3,090,909 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company. The stock was offered at $1.65 per share for gross proceeds of approximately $5.1 million, less underwriting discounts and other offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $8 Million Public Offering

genetic technologies logo

Press Release – New York, NY – May 28, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a public offering of 4,000,000 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman, counsel Jeffrey Cahlon, and associate Yian Pan.

Sichenzia Ross Ference LLP Represents ThinkEquity in $5 Million Public Offering of Medigus Ltd 

Medigus Ltd logo

Press Release – New York, NY – May 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager in a $5 million offering of Medigus Ltd. (Nasdaq: MDGS), an Israeli technology company developing minimally-invasive tools and direct visualization technology.  

continue reading >>

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $11,250,000 Registered Direct Offering

vuzix view the future logo

Press Release – New York, New York – May 13, 2020 – Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI) in a registered direct offering of 5,000,000 shares of its common stock at a price of $2.25 per share for gross proceeds of approximately $11,250,000. 

The Sichenzia Ross Ference LLP team was led by partner Gregory Sichenzia, counsel Jeffrey Cahlon, and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement 

lexaria bioscience logo

Press Release – New York, New York – May 7, 2020 –  Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) in a private placement of common stock and warrants for gross proceeds of approximately $2 million. 

The Special Equities Group, a division of Bradley Woods & Co. Ltd., acted as the exclusive placement agent for the offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital in $3.15 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – April 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 12,600,000 shares of Avinger, Inc. (NASDAQ: AVGR) common stock at a price of $0.25 per share, for total gross proceeds of approximately $3.15 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners in $8.4 Million Underwritten Public Offering of Safe-T Group Ltd.

safe-t logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented A.G.P./Alliance Global Partners as sole book-running manager in an underwritten public offering of the securities of Safe-T Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions for on-premise and hybrid cloud environments. The securities offered by the company consisted of (i) 858,600 units, each comprised of one American Depositary Share (“ADS”), representing 40 ordinary shares, and one warrant to purchase one ADS (“Warrant”), and (ii) 6,777,500 pre-funded units, each comprised of one pre-funded warrant to purchase one ADS and one Warrant.  The offering price was $1.10 per unit and $1.099 per pre-funded unit. 

continue reading >>

Sichenzia Ross Ference LLP Represents Beyond Air in $50 Million At-The-Market Offering

beyond air logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: “XAIR”), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, in an At-The-Market Offering (“ATM”) under which the Company may offer and sell from time to time shares of its common stock having an aggregate offering price of up to $50,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.44 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 722,502 American Depositary Shares (ADSs), each representing 600 of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.8 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 3, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 1,028,574 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $1.75 per ADS.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $7.7 Million Overnight Bought Offering of Cel-Sci Common Stock

cel sci

Press Release – New York, NY – March 26, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book-running manager in an offering of 630,500 shares of the common stock of Cel-Sci Corporation (NYSE American: CVM), a biotechnology company. The stock was offered at $12.22 per share for gross proceeds of approximately $7.7 million, less underwriting discounts and other offering expenses.  

continue reading >>

Sichenzia Ross Ference LLP Represents Pareteum Corporation in $3.75 Million Offering of Series C Preferred Stock

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Pareteum Corporation (NASDAQ: TEUM), a cloud communications platform company, as it entered into a subscription agreement with certain investors for shares of the company’s 8% Series C Redeemable Preferred Stock at a purchase price of $100,000 per share for gross proceeds of $3,750,000.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associate Grant Levine.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $2.9 Million Public Offering of Digital Ally, Inc. Common Stock 

digital ally logo

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,521,740 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company. The stock was offered at $1.15 per share for gross proceeds of approximately $2.9 million, less underwriting discounts and other offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Alliance Global Partners as Placement Agent in $10M Registered Direct Offering of Aptorum Group Limited

Aptorum logo

Press Release – New York, NY – February 28, 2020 – Sichenzia Ross Ference LLP announced today that it represented Alliance Global Partners as lead placement agent in a registered direct offering of 1,351,350 Class A ordinary shares of Aptorum Group Limited (Nasdaq: “APM”), a biopharmaceutical company. The offering price was $7.40 per share for gross proceeds of $10 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $4.6 Million Public Offering of Common Stock 

document security systems logo

Press Release – New York, NY – February 25, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and diversion protection technologies, in the underwritten public offering of 22,222,223 common shares, plus 3,333,333 shares from the exercise of the underwriter’s purchase option to cover overallotments, at a price of $0.18 per share for gross proceeds of $4.6 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.6 Million Offering of Medalist Series A Stock

medalist diversified reit logo

Press Release – New York, NY – February 19, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 200,000 shares of 8% Series A Cumulative Redeemable Preferred Stock of Medalist Diversified REIT, Inc. (Nasdaq:MDRR), a real estate investment trust specializing in the acquisition, ownership and management of value-add commercial real estate.  The shares were sold at an offering price of $23.00 per share for gross proceeds of $4.6 million and commenced trading on the Nasdaq Capital Market under the symbol “MDRRP.”

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $8.1 Million Offering and NASDAQ Listing of Duos Technologies Common Stock

duostech logo

Press Release – New York, NY – February 18, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager and The Benchmark Company as co-manager in an $8.1 million offering of common stock at $6.00 per share of Duos Technologies Group, Inc. (NASDAQ: DUOT). Simultaneously with the offering, the common stock was approved for listing on the Nasdaq Capital Market and began trading on February 13, 2020 under the symbol DUOT. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Follow-On Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – February 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 6,428,572 shares of the common stock of Avinger, Inc.  (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease, at an offering price of $0.70 per share for gross proceeds of $4.5 million. The shares are being offered and sold pursuant to Avinger’s effective registration statement on Form S-1 (Registration No. 333-235902).

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P. in $2.2 Million Common Stock Offering

co crystal pharma inc

Press Release – New York, NY – January 31, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a $2.2 million offering of common stock at $0.63 per share of Cocrystal Pharma, Inc.  (NASDAQ: COCP), a clinical stage biotechnology company developing antiviral therapeutics.  The shares were offered and sold pursuant to Cocrystal’s effective registration statement on Form S-3 (Registration No. 333-220632).

continue reading >>

Sichenzia Ross Ference LLP Represents HiVentures Zrt., a Hungarian Venture Capital Company, in Private Placement of Series A Preferred Stock of ActiveGraf

activegraf logo

Press Release – New York, NY – January 16, 2020 – Sichenzia Ross Ference LLP announced today that it represented MFB Növekedési Tökealap, a Hungarian investment firm, and its manager, Hiventures Zrt., a state-owned venture capital company committed to the promotion of Hungarian start-ups and businesses, in connection with their agreement to purchase approximately $900,000 of Series A preferred stock of ActiveGraf Inc., a private North Carolina-based company creating interactive data analytics.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners as Sole Placement Agent in $3M Registered Direct Offering of Cellect Biotechnology Ltd.

cellect logo

Press Release – New York, NY – January 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of 1,000,000 American Depositary Shares (“ADSs”) of Cellect Biotechnology Ltd (Nasdaq: “APOP”), a developer of innovative technology enabling the functional selection of stem cells. Each of the ADSs represents 100 of APOP’s ordinary shares. The offering price was $3.00 per ADS for gross proceeds of approximately $3,000,000, less fees and other estimated offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $5.5 Million Follow-On Offering of CEL-SCI Corporation Common Stock

cel sci

Press Release – New York, NY – December 30, 2019 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 606,395 shares of the common stock of CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, at an offering price of $9.07 per share, for gross proceeds of $5.5 million. Pursuant to the terms of the underwriting agreement, Aegis has been granted a 45-day option to purchase up to an additional 90,959 shares of CEL-SCI common stock to cover over-allotments.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio, Avital Perlman and Marcelle Balcombe and associates Grant Levine and Jacob Tabman.

Sichenzia Ross Ference LLP Represents Biotricity Inc. in a $6 Million Private Placement of its Series A Convertible Preferred Stock

biotricity logo

Press Release – New York, New York – December 19, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, in connection with the sale of $6M of its Series A convertible preferred stock.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia and David Manno.

Sichenzia Ross Ference LLP Represents Beyond Air, Inc. in a $11.5 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement

beyond air logo

Press Release – New York, NY – December 12, 2019 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a clinical stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for treatment of severe respiratory conditions, in the successful completion of an underwritten public offering and concurrent private placement of approximately $11.5 million of Beyond Air common stock at a price of $3.66 per share. The public offering was conducted from an effective shelf registration statement filed with the Securities and Exchange Commission.  The private placement shares will not be registered.

continue reading >>

Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock

relmada

Press Release – New York, NY – December 6, 2019 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a clinical stage company developing depression and central nervous system disease therapies, in the successful completion of an underwritten public offering of three million shares of Relmada common stock at a price of $30.00 per share.

The underwriters exercised their over-allotment option for an additional 450,000 shares, bringing gross proceeds to $115 million before the deduction of underwriting discounts, commissions, and other estimated offering expenses. Jefferies, SVB Leerink, and Guggenheim Securities are joint book running managers for the offering.

Relmada intends to use the net proceeds to fund research and development for clinical stage programs related to its lead product candidate, REL-1017 (d-methadone), an oral agent for depression which recently produced favorable results in clinical trials.

Sichenzia Ross Ference LLP also represented Relmada in the listing of its Common Stock on the Nasdaq Capital Market, which commenced trading on October 10, 2019. The firm joined Relmada and its executive leadership at its Nasdaq Bell Ringing Ceremony on October 17.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, Barrett DiPaolo, Thomas Rose and Associate Grant Levine.

Sichenzia Ross Ference Represents H-Cyte, Inc. in $6.0 Million Private Placement

H-Cyte

Press Release – New York, NY – December 2, 2019 –  Sichenzia Ross Ference LLP acted as H-Cyte’s counsel in a $6.0 million private placement with FWHC, LLC at a price in excess of the market price. H-Cyte is the owner and operator of innovative medical technology products and services including LungCYTE and The Lung Health Institute. H-Cyte intends to utilize the funds to advance its development of industry-leading medical treatments for chronic lung diseases such as COPD. The SRF team was led by partner, Arthur Marcus.

Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $3.5 Million Public Offering for Safe-T Group Ltd.

safe-t

Press Release – New York, NY – November 5, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and warrants of Safe-T Group Ltd., a provider of Secure Access solutions for on-premise and hybrid cloud environments (NASDAQ, TASE: SFET).

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in a $1.8 Million Private Placement

document security systems logo

New York, NY – November 5, 2019 – Sichenzia Ross Ference LLP, announced today that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and consumer engagement technology, in a private placement of 6,000,000 shares of the company’s common stock at a purchase price of $0.3037 per share. DSS received gross proceeds of $1,822,200 from the offering, which was funded entirely by the company’s Chairman of the Board of Directors, Mr. Heng Fai Ambrose Chan. continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $3 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

co crystal pharma inc

Press Release – New York, NY – November 4, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,529,412 shares of Cocrystal Pharma, Inc. (NASDAQ: COCP) common stock, at a price of $0.85 per share for gross proceeds of approximately $3.0 million. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics. continue reading >>

Sichenzia Ross Ference Represents Pareteum Corporation in $40 Million Offering of Common Stock and Warrants

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – September 27, 2019 – Nationally-recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: “TEUM”), global cloud software communications platform company, in an underwritten public offering of 18,852,273 Common Stock Units, each consisting of one share of TEUM’s common stock, one Series A Purchase Warrant to purchase one share of TEUM’s common stock, and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock, and 3,875,000 Pre-Funded Units, consisting of one pre-funded warrant to purchase one share of TEUM’s common stock together with one Series A Purchase Warrant to purchase one share of TEUM’s common stock and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – August 26, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,813,559 shares of Avinger, Inc. (NASDAQ: AVGR) common stock, at a price of $1.18 per share for gross proceeds of approximately $4.5 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $2.3 Million Public Offering of Common Stock of Sigma Labs, Inc.

sigma labs logo

Press Release – New York, NY – August 2, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 2.875 million shares Common Stock of Sigma Labs, Inc. (NASDAQ: SGLB) at a price of $.80 per share for gross proceeds of $2.3 million.  Sigma Labs is a provider of quality assurance software under the PrintRite3D brand.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $1.35 Million Underwritten Public Offering of ADSs of Immuron Limited

immuron logo

Press Release – New York, NY – July 23, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, as sole book runner in a $1.35 million Public Offering of the ADSs of Immuron Limited (NASDAQ “IMRN” ASX.”IMC”). The offering consisted of 339,130 ADS’s at a price of $4.00 per ADS for gross proceeds to the Company of $1.35 million. Immuron is an Australian biopharmaceutical company focused on oral immunoglobulin therapeutics. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Tara Guarneri-Ferrara.

continue reading >>

Sichenzia Ross Ference LLP Represents RealWear, Inc. in $80 Million Financing Transactions

realwear inc logo

Press Release — July 9, 2019 — New York, NY — Sichenzia Ross Ference LLP represented RealWear, Inc., an innovative technology company whose flagship product, the HMT-1®, is the first ruggedized head-mounted, wearable, Android-class tablet computer that frees a worker’s hands for dangerous jobs, in financing transactions raising an aggregate of $80 million. The Series B financing round was led by Teradyne, Inc. (TER), a global leader in industrial automation, and included participation from other industry leaders including Qualcomm Ventures and Bose Ventures. JPMorgan Chase & Co. acted as the exclusive placement agent to RealWear, Inc. in connection with the Series B financing.

continue reading >>

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $20 Million Registered Direct Offering

vuzix

Press Release – New York, NY – July 8, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of approximately 5.48 million registered shares of common stock at a price of $3.65 per share and approximately 5.48 million common stock purchase warrants with an exercise price of $4.10 per share  for gross proceeds to Vuzix of approximately $20 million. The Special Equities Group, a division of Bradley Woods & Co. Ltd. acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Tara Guarneri-Ferrara, and Counsel Jeff Cahlon.

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $5.6 Million Underwritten Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented its client, Document Security Systems, Inc. (NYSE American: DSS), in a $5.6 million public offering of its common stock.  The offering consisted of 11.2 million shares of common stock at a price of $0.50 per share. Aegis Capital Corp. served as sole book running manager in connection with the offering. DSS is a leader in the anti-counterfeit, authentication and diversion protection technology space. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia, Darrin Ocasio, Tara Guarneri-Ferrara and Jeffrey D’Angelo.

Sichenzia Ross Ference LLP Represents Medicine Man Technologies, Inc. in Private Placement Offering of up to $14 Million

medicine man technologies

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Medicine Man Technologies, Inc. (OTC: MDCL) (“Medicine Man or the “Company”) in a securities purchase agreement with Dye Capital & Co. for the sale of up to $14 million of shares and common stock purchase warrants of the Company. The shares were sold at a price of $2.00 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $3.0 Million Registered Direct Offering of Common Stock and Warrants of General Cannabis Corp.

Press Release­­ – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that it has represented a FINRA member firm as financial advisor in the registered direct offering of 3.0 million shares of common stock and 3.0 million warrants of General Cannabis Corp. (OTCQX: CANN) at a price of $1.00 per share for gross proceeds of approximately $3.0 million.

continue reading >>

Sichenzia Ross Ference LLP Represents AIT Therapeutics in $8 Million Private Placement

AIT therapeutics

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.0 Million Public Offering of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP (SRF) announced today that it has represented Aegis Capital Corp. as sole book-running manager in the underwritten public offering of 1.66 million shares Common Stock of Medalist Diversified REIT, Inc.(NASDAQ: MDRR) at a price of $4.80 per share for gross proceeds of $8.0 million.

continue reading >>

Sichenzia Ross Ference LLP Announces $1.3 million Private Placement of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as placement agent in a private offering of 270,833 shares of Common Stock of Medalist Diversified REIT, Inc. (NASDAQ: MDRR) at a purchase price of $4.80 per share for gross proceeds of approximately $1.3 million.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $2.0 Million Underwritten Public Offering of ADSs of Immuron Limited.

immuron logo

Press Release – New York, NY – May 29, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, Inc. as sole book runner in a $2.0 million Public Offering of American Depositary Shares (ADSs) of Immuron Limited (ASX: “IMC”; NASDAQ “IMRN”).

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) in Offering of $1.2 Million American Depositary Shares

genetic technologies logo

Press Release – New York, NY – May 23, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE), a diversified molecular diagnostics company, in a registered direct offering of American Depositary Shares (“ADSs”) and warrants to purchase ADSs.  The Company received gross proceeds of approximately $1,200,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Quest Solutions, Inc. in $5 Million Private Placement

quest solution

Press Release – New York, NY – April 9, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Quest Solution, Inc.  (OTCQB: QUES) in the private placement of 16,666,667 unregistered shares of its common stock, at a purchase price of $.30 per share, for gross proceeds of approximately $5,000,000. Investors also received warrants to purchase 16,666,667 shares of common stock at an exercise price of $.35 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $25 Million Credit Facility with East West Bank

new age beverage corp. logo

Press Release – New York, NY – April 2, 2019 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in a loan and security agreement with East West Bank which provides for up to $25 million aggregate principal amount revolving credit facility, which includes a $15 million term loan and a feature to provide an additional $10 million should the company choose to utilize it and a $10 million revolving line of credit.

continue reading >>

Sichenzia Ross Ference LLP Represents LiveWell Canada Inc. in $15 Million Private Placements to Scale its CBD Operations

live well

Press Release – New York, NY – March 28, 2019 – Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that it represented LiveWell Canada Inc. (“LiveWell”), a Canadian CBD company listed on the Canadian Stock Exchange entering the U.S. markets, in a private placement offering of senior secured convertible notes with institutional investors for total aggregate gross proceeds of $15 million, which includes LiveWell’s previously closed $3 million bridge financing.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $5.4 Million Public Offering of Common Stock of Opgen, Inc.

opgen logo

Press Release – New York, NY – March 28, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 9 million shares Common Stock of Opgen, Inc. (NASDAQ: OPGN) at a price of $.60 per share for gross proceeds of $5.4 million.  Opgen is a precision medicine company harnessing the power of molecular diagnostics to combat infectious disease. The Sichenzia Ross Ference LLP team was led by partners Tom Rose, Gregory Sichenzia and Jay Yamamoto.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference Represents Pareteum Corporation in $50 Million Credit Facility with Post Road Group

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – March 20, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a global cloud software communications platform company, as it closed a $50,000,000 committed senior secured credit facility with Post Road Group. Under the terms of the credit facility, Post Road provided Pareteum an initial loan of $25,000,000 on February 26, 2019, with additional loans in increments of $5,000,000 to be made as requested by Pareteum before the 18-month anniversary of the initial funding date.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associates Grant Levine and Huan Lou.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference Represents Pareteum Corporation in Tender Offer for Shares of iPass, Inc. and Completes Acquisition

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – February 14, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a cloud software platform, as it accepted for exchange shares  of iPass, Inc. (Nasdaq: IPAS), a provider of global mobile connectivity.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $6.5 Million Public Offering for Cellect Biotechnology Ltd.

cellect logo

Press Release – New York, NY – February 12, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and Warrants of Cellect Biotechnology Ltd., an Israeli biotech company (NASDAQ: APOP). National Securities Corporation and Dawson James Securities, Inc. acted as co-managers for the offering.

continue reading >>

Sichenzia Ross Ference LLP Represents INmune Bio Inc. in an $8 Million Initial Public Offering and Listing on the Nasdaq Capital Market

inmunebio logo

Press Release – New York, NY – February 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented INmune Bio Inc. (INMB), an immunotherapy company focused on developing therapies that harness the patient’s innate immune system to fight disease, in an initial public offering at a price of $8.00 per share resulting in gross proceeds of approximately $8,000,000 and listing on the Nasdaq Capital Market under the ticker symbol INMB.

continue reading >>

Sichenzia Ross Ference LLP Represents Boulder Botanicals & Biosciences Laboratories, Inc. in a $5.0 Million Private Placement

boulder botanicals

Press Release – New York, NY – January 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented Boulder Botanicals & Biosciences Laboratories, Inc.  (BBBL), a holding company which owns and operates several companies operating within the CBD production, extraction and distribution industries in a private placement of shares of common stock at a price of $1.00 per share resulting in gross proceeds of approximately $5,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to China SXT Pharmaceuticals, Inc.’s $10.2 Million U.S. Initial Public Offering

china sxt pharmaceuticals

Press Release – New York, NY – January 4, 2019 – Sichenzia Ross Ference LLP congratulates China SXT Pharmaceuticals, Inc. (the “Company”) (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (“TCMPs”), on the final closing of its initial public offering on January 3, 2019. Together with the first closing on December 31, 2018, the Company raised approximately $10.2 million in gross proceeds, before deducting underwriting discounts, commissions and other offering expenses, by issuing 2,546,275 ordinary shares at a public offering price of $4.00 per share. The shares are scheduled to commence trading on the NASDAQ Capital Market today at around 2:05 p.m. ET under the ticker symbol “SXTC.”

continue reading >>

Sichenzia Ross Ference LLP Represents New Age Beverages Corporation in the $85 Million Acquisition of Morinda Holdings, Inc.

new age beverage corp. logo

NEW YORK, Jan. 03, 2019 — Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that its mergers and acquisitions team represented New Age Beverages Corporation (NASDAQ:NBEV) in its acquisition of Morinda Holdings, Inc., a Utah-based healthy beverages and lifestyle company with operations in more than 60 countries worldwide.

The consideration for the merger was $85 million, comprised of $75 million in cash and $10 million paid in 2,016,480 shares of New Age common stock based on the 40-day volume-weighted average price calculated through December 20, 2018. The transaction was subject to the pre-merger notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended and closed on December 21, 2018.

The full Sichenzia Ross release can be found here.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P/Alliance Global Partners in $10 Million Public Offering for Creative Realities, Inc.

creative realities logo

Press Release – New York, NY – November 19, 2018 –  Sichenzia Ross Ference LLP announced today that it has represented A.G.P/ Alliance Global Partners  (through Euro Pacific Capital) as sole book running manager in the underwritten public offering of shares of Common Stock and Warrants of Creative Realities, Inc. (NASDAQ: CREX).

continue reading >>

Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $52 Million Underwritten Public Offering

new age beverage corp. logo

Press Release – New York, NY – November 14, 2018 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in an underwritten public offering of 14,835,000 shares of its common stock, which includes a full simultaneous exercise of the underwriters 15% over allotment option, at a public offering price of $3.50 per share for gross proceeds to NBEV of $51,922,500. Roth Capital Partners and A.G.P/ Alliance Global Partners acted as joint book-running managers for the offering. Please click here to read the full Sichenzia Ross release.

continue reading >>

Sichenzia Ross Ference Represents Pareteum Corporation in Definitive Agreement to Acquire iPass, Inc.

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – November 13, 2018 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a cloud software platform, as it entered into a definitive agreement under which it will acquire iPass, Inc. (Nasdaq: IPAS), a provider of global mobile connectivity, in an all-stock transaction. Pareteum anticipates achieving more than $15 million in annual cost synergies; more than $12 million of such synergies are expected to be realized in the first year.

continue reading >>

Sichenzia Ross Ference LLP Represents Novume Solutions, Inc. in $3.3 Million Underwritten Public Offering of Common Stock

novume logo

Press Release – New York, NY – November 1, 2018 – Sichenzia Ross Ference LLP announced today that it has represented Novume Solutions, Inc. (NASDAQ “NVMM”) in a public offering of 4.125 million shares of its common stock at a price of $.80 per share for gross proceeds to the Company of $3.3 million.
continue reading >>

Sichenzia Ross Ference LLP Represents Wize Pharma, Inc. in a $4.45 Million Private Placement

wize pharma

New York, NY – October 24, 2018 – Sichenzia Ross Ference LLP, announced today that it represented Wize Pharma, Inc. (OTCQB: “WIZP”), a clinical stage Israel based U.S. public company focused on the treatment of ophthalmic disorders company, in a private placement with institutional and accredited investors  of 3,100,000 shares of common stock at $1.00 per share and 1,350 shares of newly created Series A preferred stock which is convertible at $1.00 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents Rodman & Renshaw a Unit of H.C Wainwright in a $15 Million Upsized Public Offering of Medical Transcript Billing, Corp.

mtbc.com logo

Press Release – New York, NY – October 15,  2018 – Sichenzia Ross Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity, a division of Fordham Financial Management as Sole Book-Running Manager on $10 Million Public Offering of Securities of  FlexShopper, Inc.

flexshopper

Press Release – New York, NY – October 1, 2018 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a division of Fordham Financial Management, Inc. as sole book-running manager in an underwritten public offering of $10 Million of Units of FlexShopper, Inc. (Nasdaq FPAY).

continue reading >>

1 2 3 6